GB0506670D0 - Method - Google Patents
MethodInfo
- Publication number
- GB0506670D0 GB0506670D0 GB0506670A GB0506670A GB0506670D0 GB 0506670 D0 GB0506670 D0 GB 0506670D0 GB 0506670 A GB0506670 A GB 0506670A GB 0506670 A GB0506670 A GB 0506670A GB 0506670 D0 GB0506670 D0 GB 0506670D0
- Authority
- GB
- United Kingdom
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0506670A GB0506670D0 (en) | 2005-04-01 | 2005-04-01 | Method |
PCT/GB2006/001136 WO2006103421A2 (en) | 2005-04-01 | 2006-03-29 | Method for predicting the response to receptor tyrosine kinase inhibitors |
TW095111374A TW200720440A (en) | 2005-04-01 | 2006-03-31 | Method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0506670A GB0506670D0 (en) | 2005-04-01 | 2005-04-01 | Method |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0506670D0 true GB0506670D0 (en) | 2005-05-11 |
Family
ID=34586567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0506670A Ceased GB0506670D0 (en) | 2005-04-01 | 2005-04-01 | Method |
Country Status (3)
Country | Link |
---|---|
GB (1) | GB0506670D0 (en) |
TW (1) | TW200720440A (en) |
WO (1) | WO2006103421A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008088885A2 (en) * | 2007-01-18 | 2008-07-24 | Creighton University | Epidermal growth factor receptor mutations and methods of use |
US9994914B2 (en) | 2014-10-09 | 2018-06-12 | Roche Molecular Systems, Inc. | Mutation in the epidermal growth factor receptor kinase domain |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005094357A2 (en) * | 2004-03-31 | 2005-10-13 | The General Hospital Corporation | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
EP1766068A4 (en) * | 2004-06-04 | 2010-03-03 | Genentech Inc | Egfr mutations |
TW200617396A (en) * | 2004-10-06 | 2006-06-01 | Astrazeneca Ab | Method |
-
2005
- 2005-04-01 GB GB0506670A patent/GB0506670D0/en not_active Ceased
-
2006
- 2006-03-29 WO PCT/GB2006/001136 patent/WO2006103421A2/en not_active Application Discontinuation
- 2006-03-31 TW TW095111374A patent/TW200720440A/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW200720440A (en) | 2007-06-01 |
WO2006103421A2 (en) | 2006-10-05 |
WO2006103421A3 (en) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1864785A4 (en) | Seterolithography method | |
GB0504774D0 (en) | Method | |
GB0503836D0 (en) | Method | |
GB0512214D0 (en) | Method | |
GB0519303D0 (en) | Chemo-immunotherapy method | |
GB0520375D0 (en) | Method | |
GB0509433D0 (en) | Method | |
GB0504096D0 (en) | Method | |
GB0507123D0 (en) | Method | |
GB0504184D0 (en) | Method | |
GB0520235D0 (en) | Method | |
GB0510536D0 (en) | Method | |
GB0508420D0 (en) | Method | |
GB0505756D0 (en) | Method | |
GB0502046D0 (en) | Method | |
GB0509305D0 (en) | Method | |
GB0515695D0 (en) | Method | |
GB0509437D0 (en) | Method | |
GB0520981D0 (en) | Method | |
GB0518667D0 (en) | Method | |
GB0504182D0 (en) | Method | |
GB0509956D0 (en) | Method | |
GB0506670D0 (en) | Method | |
GB0502360D0 (en) | Method | |
GB0520325D0 (en) | Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |